Praxis Precision Medicines Inc. PRAX
$261.90
▲ +7.50% 24H
About
Praxis Precision Medicines Inc. operates within the biopharmaceutical sector, focusing on the development of treatments for central nervous system (CNS) disorders. The company's primary objective is to address unmet medical needs by leveraging their extensive research in genetics, the neurobiology of CNS disorders, and…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees168
TickerPRAX
Statistics
Market Cap$7.30B
Revenue (TTM)$0
Net Income-$303.3M
Net Margin—
EPS$-13.48
P/E-19.54
P/S—
P/B4.90
EV/EBITDA-16.58
ROE-35.3%
Dividend Yield—
Price$261.90
Data: Twelve Data · Revenue = mcap / P/S